Physician profile
Daniel E Galvin
NPI 1780649343
$269.74
in general payments reported to CMS, 2019-2025
7 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2023: $15.76 · 2024: $26.88 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143 · Education: $26.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.77 |
| Education | $26.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $77.03 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $69.26 | 2019 | |
| Acell, INC. | $30.83 | 2019 | |
| Karl Storz Endoscopy-America | $26.92 | 2025 | Spies |
| Astrazeneca Pharmaceuticals Lp | $26.88 | 2024 | Andexxa |
| Davol INC. | $23.06 | 2025 | Phasix Mesh |
| Boston Scientific Corporation | $15.76 | 2023 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Galvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.